United StatesÚltimas notícias

Thailand released 18 Cambodian soldiers under a fragile ceasefire, as both sides seek to ease weeks of deadly border clashes and mass displacement.

Protests in Iran have intensified for a fourth day as demonstrators targeted a government building, driven by anger over a collapsing currency and economic pressure.

Congress has released Jack Smith’s testimony defending his Trump prosecutions, detailing evidence claims and warning of potential political retribution.

Trump Media plans to issue a new cryptocurrency to shareholders via Crypto.com, deepening the Trump family’s push into digital assets amid ongoing market volatility.

A US investment bank upgraded TeraWulf shares after lifting its price target, citing strong growth potential from a shift toward high-performance computing alongside Bitcoin mining.

Several crypto billionaires suffered heavy losses in 2025 after an October market slide, even as a small number of industry figures posted strong gains.

Bitcoin could see strong price momentum in 2026 as expected US liquidity injections support risk assets, even as analysts warn that political and macroeconomic uncertainty may limit gains.

Matthews International Corporation (NASDAQ:MATW) officially closed the sale of its Warehouse Automation business to Duravant on Wednesday, December 31, 2025.

The deal, first announced in mid-November, provides the Pittsburgh-based firm with $232.1 million in total consideration, including $225.4 million in cash.

Mitsubishi UFJ Financial Group (NYSE:MUFG) has elected Carolyn DuChene to the Board of Directors of MUFG Americas Holdings Corporation and the MUFG U.S. Advisory Board, effective January 1, 2026.

Ondas Holdings (NASDAQ:ONDS) closed out a transformational fiscal year on Wednesday, announcing approximately $10 million in new purchase orders for its autonomous systems portfolio.

DigitalBridge (NYSE:DBRG) and Crestview Partners have completed their $1.5 billion take-private acquisition of WideOpenWest (WOW!), concluding the transaction on December 31, 2025.

FibroBiologics (NASDAQ:FBLG) took a decisive step toward clinical-stage operations on Wednesday, filing an Investigational New Drug (IND) application with the U.S. Food and Drug Administration to begin Phase 1/2 trials for its lead psoriasis candidate, CYPS317.